Mobia Medical Announces Pricing of Initial Public Offering
Mobia Medical
May 8, 2026
Odyssey Health, Inc. has completed the acquisition of Odyssey Medical Devices, Inc., a medical devices business in Nevada. Odyssey Medical Devices develops and sublicenses BreastCheck device technology, supporting medical diagnostics commercialization under a technology and material transfer framework. The company’s licensing arrangement with NeuRX Health, Inc. includes cash consideration tied to net cash proceeds from an equity line of credit, with 10% initially and 30% after specified technology and material transfer agreement terms are met. This healthcare M&A transaction is categorized as other acquisition and reflects healthcare deals NV activity focused on medical devices acquisition and NV acquisitions, with amendment terms effective April 21, 2026.
Mobia Medical
May 8, 2026
Stryker→Amplitude Vascular Systems
May 8, 2026
Odyssey Therapeutics
May 8, 2026
Odyssey Therapeutics
May 8, 2026
Angelini Pharma→Catalyst Pharmaceuticals
May 7, 2026